Abstract
A 6-week, parallel, randomized, open-label study was conducted to evaluate the effects of bentazepam 75 mg/day versus those of clorazepate 30 mg/day in 50 patients with anxiety disorders. Both drugs reduced anxiety as measured by the Hamilton Anxiety Scale (HAS) and the State-Trait Anxiety Inventory (STAI). The mean HAS and STAI scores at weeks 1, 3, and 6 in patients receiving bentazepam were significantly lower than those of patients receiving clorazepate. Patients taking bentazepam also exhibited improved performance on cognitive tests (Digit-Symbol Substitution Test and Digit Span). Although further studies are needed, bentazepam seems to differ from classic benzodiazepines with regard to its effects on cognitive function.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
